Abbott/$ABT
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About Abbott
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Ticker
$ABT
Sector
Primary listing
NYSE
Employees
114,000
Headquarters
Website
Abbott Metrics
BasicAdvanced
$224B
16.15
$7.96
0.72
$2.36
1.84%
Price and volume
Market cap
$224B
Beta
0.72
52-week high
$141.23
52-week low
$110.86
Average daily volume
6.6M
Dividend rate
$2.36
Financial strength
Current ratio
1.703
Quick ratio
1.088
Long term debt to equity
22.686
Total debt to equity
26.501
Dividend payout ratio (TTM)
28.93%
Interest coverage (TTM)
16.93%
Profitability
EBITDA (TTM)
11,747
Gross margin (TTM)
56.26%
Net profit margin (TTM)
31.88%
Operating margin (TTM)
19.65%
Effective tax rate (TTM)
-71.75%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
6.79%
Return on equity (TTM)
30.62%
Valuation
Price to earnings (TTM)
16.147
Price to revenue (TTM)
5.101
Price to book
4.42
Price to tangible book (TTM)
10.45
Price to free cash flow (TTM)
32.345
Free cash flow yield (TTM)
3.09%
Free cash flow per share (TTM)
3.974
Dividend yield (TTM)
1.84%
Forward dividend yield
1.84%
Growth
Revenue change (TTM)
6.37%
Earnings per share change (TTM)
141.97%
3-year revenue growth (CAGR)
-0.89%
10-year revenue growth (CAGR)
7.86%
3-year earnings per share growth (CAGR)
21.57%
10-year earnings per share growth (CAGR)
10.24%
3-year dividend per share growth (CAGR)
7.87%
10-year dividend per share growth (CAGR)
9.41%
What the Analysts think about Abbott
Analyst ratings (Buy, Hold, Sell) for Abbott stock.
Abbott Financial Performance
Revenues and expenses
Abbott Earnings Performance
Company profitability
Abbott News
AllArticlesVideos
Abbott issues US device correction for some glucose monitors over faulty readings risk
Reuters5 days ago
Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
Business Wire1 week ago
Abbott to buy Exact Sciences for $21B in cancer diagnostics reach push
Proactive Investors1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Abbott stock?
Abbott (ABT) has a market cap of $224B as of November 29, 2025.
What is the P/E ratio for Abbott stock?
The price to earnings (P/E) ratio for Abbott (ABT) stock is 16.15 as of November 29, 2025.
Does Abbott stock pay dividends?
Yes, the Abbott (ABT) stock pays dividends to shareholders. As of November 29, 2025, the dividend rate is $2.36 and the yield is 1.84%. Abbott has a payout ratio of 28.93% on a trailing twelve-month basis.
When is the next Abbott dividend payment date?
The next Abbott (ABT) dividend payment date is unconfirmed.
What is the beta indicator for Abbott?
Abbott (ABT) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.